Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients With Advanced Neuroendocrine Tumors.
Article in JCO Oncology Practice (June 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Article in JCO Oncology Practice (June 2024)
Article in Archives of Endocrinology and Metabolism (May 2024)
Article in Endocrine Related Cancer (February 2024)